Sanyo’s MIR-S100C compact orbital shaker is for use in high humidity and/or elevated CO2 concentration conditions. With the orbital shaker mounted inside the incubator and an independent controller placed externally, the MIR-S100C offers simple, secure operation for cell culture applications within GMP environments.
The MIR-S100C incorporates antibacterial copper alloy stainless steel for the shaker section, with a small window that can be used for spraying disinfectant inside. The controller is a separate unit, preventing humidity from affecting the electrical components and enabling operation to be monitored without opening the incubator.
Revolution speed is adjustable from 40–200rpm and the timer can be set for up to 99.9 hours or continuous operation. A soft start function protects against spillage or foaming of samples inside flasks and test tubes by gradually accelerating at a selectable speed until the preset number of revolutions is reached.
Features include a non-volatile memory facilitating automatic recovery after a power cut, speed error alarm and motor overload protection circuit to ensure security of operation. A maintenance-required indicator is provided for timely replacement of belt and bearings, and therefore more secure continuous operation.
Optional accessories include a platform on which cultures may be placed and clamps and racks for a variety of flasks and tubes.
MIR-S100C offers secure operation for cell culture
For use in high humidity conditions
You may also like
Trending Articles
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Manufacturing
Accelerating the development of bispecific antibodies
Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains how the use of comprehensive tailored approaches can enhance bispecific antibody productivity, stability and quality while accelerating their delivery to market
Manufacturing
Nemera partners with Therakind to expand nasal drug delivery portfolio with DriDose dry powder platform
The manufacturer has announced a strategic partnership with UK pharmaceutical company Therakind to advance the DriDose intranasal dry powder platform, adding dry powder delivery capabilities to complement Nemera's existing liquid nasal formulation offering